# The Branded Health Service Medicines (Costs) (Amendment) Regulations 2022, Regulation 2: Amendment of the Branded Health Service Medicines (Costs) Regulations 2018


(1) The Branded Health Service Medicines (Costs) Regulations 2018 are amended as follows.
(2) In regulation 3 (payment scheme)—
(a) in paragraph (1), for the table substitute the following table—
“
Table
Applicable Period
Payment Percentage
1st July 2022 to the end of 2022
14.3%
2023 and any subsequent calendar year
24.4%
”;
(b) in paragraph (1B)—
(i) for “1st April 2020 to the end of 2020” substitute “1st July 2022 to the end of 2022”;
(ii) for “5.0%” substitute “17.7%”, and
(iii) for “7.4%” substitute “14.3%”; and
(c) in paragraph (1C)—
(i) for “1st April 2020 to the end of 2020” substitute “1st July 2022 to the end of 2022”;
(ii) in sub-paragraph (a)—
(aa) for “1st January 2020” substitute “1st January 2022”, and
(bb) for “31st March 2020” substitute “30th June 2022”, and
(iii) in sub-paragraph (b), for “14.7%” substitute “10.9%”.

---
Source: https://www.legislation.gov.uk/uksi/2022/593/regulation/2 (the official version)
Page: https://openlegislation.uk/branded-health-service-medicines-costs-amendment-regulations-2022/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.